9amHealth Secures $26M Series B Funding

Why It Matters

The $26 million infusion enables 9amHealth to scale its remote specialty services, meeting surging demand for telehealth and sharpening its competitive position in a fast‑growing market.

Key Takeaways

• $26M Series B led by Define Ventures.
• New investors: SemperVirens VC, Catalio Capital, NewHealth Ventures.
• Funding targets expansion of virtual specialty care services.
• Highlights investor confidence in telehealth market growth.

Pulse Analysis

The digital‑health sector has entered a new phase of maturity, with specialty care moving from pilot programs to full‑scale platforms. 9amHealth leverages a cloud‑based infrastructure to connect patients with board‑certified specialists, reducing referral delays and geographic barriers. As insurers and employers push for cost‑effective care pathways, platforms that can deliver high‑quality, reimbursable specialty visits remotely are becoming essential components of the broader telemedicine ecosystem.

The $26 million Series B round signals strong validation from the venture community. Define Ventures, known for backing early‑stage health‑tech innovators, led the round, while newcomers SemperVirens VC, Catalio Capital Management, and NewHealth Ventures added strategic depth. The investors bring not only capital but also networks in payer relations, regulatory compliance, and clinical operations, positioning 9amHealth to accelerate its go‑to‑market strategy and integrate advanced analytics into its care delivery model.

Looking ahead, the infusion of funds will likely fuel geographic expansion, recruitment of additional specialty providers, and development of AI‑driven triage tools. Competitors such as Teladoc Health and Amwell are also scaling specialty lines, so 9amHealth must differentiate through outcome‑based pricing and seamless EHR integration. If executed well, the company could capture a sizable share of the projected $150 billion U.S. tele‑specialty market by 2030, reinforcing the broader trend of digital health becoming a mainstream care channel.

Deal Summary

San Diego‑based virtual specialty care platform 9amHealth announced a $26 million Series B round led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management and NewHealth Ventures.